Innovation, inclusion, and urgency define Kigali HIV conference ANALYSIS | RONALD MUSOKE | When the 13th International AIDS Society (IAS) Conference on HIV Science (IAS 2025) concluded in Kigali after five dynamic days (July 13–17), delegates left with a mix of hope and concern—buoyed by scientific breakthroughs but unsettled by a deepening …
Read More »
But not fast enough to meet 2030 targets ANALYSIS | MELODY CHIRONDA | The Joint United Nations Programme on HIV/AIDS (UNAIDS) has warned that the global AIDS response is in crisis after a major funding collapse at the start of 2025 threatens to reverse decades of progress. New data reveals that …
Read More »
Lenacapavir, trialed in Uganda, offers 100% protection but will it reach those who need it most? Kampala, Uganda | RONALD MUSOKE | Thanks to a landmark deal announced on July 9 by the Global Fund, Uganda is expected to be among the first countries in sub-Saharan Africa to get access to …
Read More »
Kampala, Uganda | THE INDEPENDENT | HIV incidence and related deaths in sub-Saharan Africa could significantly increase following the suspension of funding for Pre-Exposure Prophylaxis (PrEP) under the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR), a new modelling study warns. The pre-print study, led by Dr. Jack Stone, Associate Professor …
Read More »
Scientific research has gifted us with a range of evidence-based options to protect ourselves from getting infected with HIV. In 2012, the U.S. Food and Drugs Authority (FDA) had first approved Pre-Exposure Prophylaxis (PrEP) daily oral medicines for HIV prevention. More recently, long-acting injectable options of PrEP are also approved. …
Read More »
Kampala, Uganda | THE INDEPENDENT | The Permanent Secretary of the Ministry of Health has expressed disappointment over poor health indicators within the population in the Greater Luwero districts despite a big budget allocation. According to the District Health report for 2023/24, at least 27% of outpatients were suffering from malaria, …
Read More »
GENEVA, Switzerland | THE INDEPENDENT | The United States Food and Drug Administration (FDA) has approved long-acting injectable lenacapavir for HIV prevention. The new medicine is administered by injection once every 6 months and is a significant step in improving prevention options for people at risk of HIV infection around the …
Read More »
Botswana has approximately 360,000 people living with HIV, with 98% of pregnant women living with HIV receiving treatment ANALYSIS | AGENCIES | In an historic global health milestone, Botswana has been validated as the first high HIV-burden country in the world, and the first in Africa, to reach the World Health …
Read More »
Kampala, Uganda | Xinhua | Uganda’s Ministry of Health on Thursday launched a nationwide HIV survey to assess progress in the fight against the virus and shape future interventions. Health Minister Ruth Aceng officially unveiled the third round of the Uganda Population-Based HIV Impact Assessment (UPHIA) 2025 in Kampala, the …
Read More »
Kampala, Uganda | THE INDEPENDENT | Quality Chemical Industries Limited (Qcil) is set to construct a second factory after it secured financing from Stanbic Bank. Qcil, Uganda’s leading manufacture of essential drugs like HIV antiretroviral pills and antimalarials, secured the $36 million (sh133 Billion ) debt facility from Stanbic Bank …
Read More »
The Independent Uganda: You get the Truth we Pay the Price
